Intravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies.

Hdl Handle:
http://hdl.handle.net/10147/207775
Title:
Intravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies.
Authors:
McAleer, M A; Bourke, J
Affiliation:
Department of Dermatology, South Infirmary-Victoria University Hospital, Cork,, Co. Cork, Ireland.
Citation:
Clin Exp Dermatol. 2011 Aug;36(6):638-40. doi: 10.1111/j.1365-2230.2011.04039.x.
Journal:
Clinical and experimental dermatology
Issue Date:
1-Feb-2012
URI:
http://hdl.handle.net/10147/207775
DOI:
10.1111/j.1365-2230.2011.04039.x
PubMed ID:
21771010
Abstract:
Human papilloma virus is a common and often distressing cutaneous disease. It can be therapeutically challenging, especially in immunocompromised patients. We report a case of recalcitrant cutaneous warts that resolved with intravenous cidofovir treatment. The patient was immunocompromised secondary to monoclonal antibody therapy for psoriasis.
Language:
eng
MeSH:
Adult; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Antiviral Agents/*administration & dosage; Cytosine/administration & dosage/*analogs & derivatives; Humans; *Immunocompromised Host; Infusions, Intravenous; Male; Phosphonic Acids/*administration & dosage; Psoriasis/*therapy; Treatment Outcome; Tumor Necrosis Factor-alpha/therapeutic use; Warts/*drug therapy
ISSN:
1365-2230 (Electronic); 0307-6938 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorMcAleer, M Aen_GB
dc.contributor.authorBourke, Jen_GB
dc.date.accessioned2012-02-01T10:43:00Z-
dc.date.available2012-02-01T10:43:00Z-
dc.date.issued2012-02-01T10:43:00Z-
dc.identifier.citationClin Exp Dermatol. 2011 Aug;36(6):638-40. doi: 10.1111/j.1365-2230.2011.04039.x.en_GB
dc.identifier.issn1365-2230 (Electronic)en_GB
dc.identifier.issn0307-6938 (Linking)en_GB
dc.identifier.pmid21771010en_GB
dc.identifier.doi10.1111/j.1365-2230.2011.04039.xen_GB
dc.identifier.urihttp://hdl.handle.net/10147/207775-
dc.description.abstractHuman papilloma virus is a common and often distressing cutaneous disease. It can be therapeutically challenging, especially in immunocompromised patients. We report a case of recalcitrant cutaneous warts that resolved with intravenous cidofovir treatment. The patient was immunocompromised secondary to monoclonal antibody therapy for psoriasis.en_GB
dc.language.isoengen_GB
dc.subject.meshAdulten_GB
dc.subject.meshAntibodies, Monoclonal/therapeutic useen_GB
dc.subject.meshAntibodies, Monoclonal, Humanizeden_GB
dc.subject.meshAntiviral Agents/*administration & dosageen_GB
dc.subject.meshCytosine/administration & dosage/*analogs & derivativesen_GB
dc.subject.meshHumansen_GB
dc.subject.mesh*Immunocompromised Hosten_GB
dc.subject.meshInfusions, Intravenousen_GB
dc.subject.meshMaleen_GB
dc.subject.meshPhosphonic Acids/*administration & dosageen_GB
dc.subject.meshPsoriasis/*therapyen_GB
dc.subject.meshTreatment Outcomeen_GB
dc.subject.meshTumor Necrosis Factor-alpha/therapeutic useen_GB
dc.subject.meshWarts/*drug therapyen_GB
dc.titleIntravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies.en_GB
dc.contributor.departmentDepartment of Dermatology, South Infirmary-Victoria University Hospital, Cork,, Co. Cork, Ireland.en_GB
dc.identifier.journalClinical and experimental dermatologyen_GB
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.